Table of Contents Author Guidelines Submit a Manuscript
Canadian Respiratory Journal
Volume 16 (2009), Suppl A, Pages 11A-16A
http://dx.doi.org/10.1155/2009/429482
Asthma Care in Canada

Montelukast as an Alternative to Low-Dose Inhaled Corticosteroids in the Management of Mild Asthma (The SIMPLE Trial): An Open-Label Effectiveness Trial

R Andrew McIvor,1 Alan Kaplan,2 Caroline Koch,3 and John S Sampalis4,5

1Firestone Institute of Respiratory Health, McMaster University, Hamilton, Canada
2York Central Hospital, Richmond Hill, Ontario, Canada
3Merck Frosst Canada Limited, Kirkland, Canada
4JSS Medical Research Inc., Montreal, Canada
5Faculty of Medicine, McGill University, Montreal, Quebec, Canada

Copyright © 2009 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

R Andrew McIvor, Alan Kaplan, Caroline Koch, and John S Sampalis, “Montelukast as an Alternative to Low-Dose Inhaled Corticosteroids in the Management of Mild Asthma (The SIMPLE Trial): An Open-Label Effectiveness Trial,” Canadian Respiratory Journal, vol. 16, no. Suppl A, pp. 11A-16A, 2009. doi:10.1155/2009/429482